Filed: 8/14/2026ACC: 0001172661-26-003750
📋 What this filing means
GREAT POINT PARTNERS LLC filed this quarterly 13F‑HR report disclosing 41 equity positions with a total reported market value of $529.12M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
41
Positions
$529.12M
Total AUM (reported)
46.71M
Total Shares
Allocation by class
COM$206.93M39.1%
SPONSORED ADS$83.10M15.7%
COM NEW$69.19M13.1%
CL A$40.88M7.7%
COM SHS$35.74M6.8%
CLASS A ORD SHS$24.87M4.7%
SHS NEW$20.34M3.8%
Portfolio Concentration
Top 3$138.10M26.1%
4–10$155.10M29.3%
11–25$173.65M32.8%
Rest$62.27M11.8%
Top 3 weight
26.1%
Top 10 weight
55.4%
Voting Authority Distribution
Total shares with voting rights: 46.71M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
46.71M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other41
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings41
Rows:
ABIVAX SA
DFNDShares604.31K
TypeSH
Market value$80.53M
15.22%
Sole
0.00
Shared
604.31K
None
0.00
VOR BIOPHARMA INC
DFNDShares1.70M
TypeSH
Market value$31.30M
5.91%
Sole
0.00
Shared
1.70M
None
0.00
IMMUNITYBIO INC
DFNDShares3M
TypeSH
Market value$26.27M
4.97%
Sole
0.00
Shared
3M
None
0.00
VERA THERAPEUTICS INC
DFNDShares600.84K
TypeSH
Market value$25.78M
4.87%
Sole
0.00
Shared
600.84K
None
0.00
ZURA BIO LTD
DFNDShares4.22M
TypeSH
Market value$24.87M
4.70%
Sole
0.00
Shared
4.22M
None
0.00
ALUMIS INC
DFNDShares856.06K
TypeSH
Market value$24.09M
4.55%
Sole
0.00
Shared
856.06K
None
0.00
SOL-GEL TECHNOLOGIES LTD
DFNDShares274.36K
TypeSH
Market value$20.34M
3.84%
Sole
0.00
Shared
274.36K
None
0.00
ULTRAGENYX PHARMACEUTICAL IN
DFNDShares600K
TypeSH
Market value$20.03M
3.79%
Sole
0.00
Shared
600K
None
0.00
DEFINIUM THERAPEUTICS INC
DFNDShares425K
TypeSH
Market value$19.99M
3.78%
Sole
0.00
Shared
425K
None
0.00
ANNEXON INC
DFNDShares3.50M
TypeSH
Market value$19.98M
3.78%
Sole
0.00
Shared
3.50M
None
0.00
ORUKA THERAPEUTICS INC
DFNDShares183.33K
TypeSH
Market value$17.45M
3.30%
Sole
0.00
Shared
183.33K
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
DFNDShares855.81K
TypeSH
Market value$16.66M
3.15%
Sole
0.00
Shared
855.81K
None
0.00
SAGIMET BIOSCIENCES INC
DFNDShares2.03M
TypeSH
Market value$15.69M
2.97%
Sole
0.00
Shared
2.03M
None
0.00
CONTINEUM THERAPEUTICS INC
DFNDShares921.48K
TypeSH
Market value$15.10M
2.85%
Sole
0.00
Shared
921.48K
None
0.00
IMMIX BIOPHARMA INC
DFNDShares1.28M
TypeSH
Market value$13.17M
2.49%
Sole
0.00
Shared
1.28M
None
0.00
CLIMB BIO INC
DFNDShares1M
TypeSH
Market value$13.04M
2.46%
Sole
0.00
Shared
1M
None
0.00
AMYLYX PHARMACEUTICALS INC
DFNDShares700K
TypeSH
Market value$12.57M
2.38%
Sole
0.00
Shared
700K
None
0.00
NEKTAR THERAPEUTICS
DFNDShares175K
TypeSH
Market value$12.22M
2.31%
Sole
0.00
Shared
175K
None
0.00
NEUROGENE INC
DFNDShares352.18K
TypeSH
Market value$11.08M
2.09%
Sole
0.00
Shared
352.18K
None
0.00
LB PHARMACEUTICALS INC
DFNDShares317.22K
TypeSH
Market value$10.30M
1.95%
Sole
0.00
Shared
317.22K
None
0.00
OPUS GENETICS INC
DFNDShares1.97M
TypeSH
Market value$8.10M
1.53%
Sole
0.00
Shared
1.97M
None
0.00
EUPRAXIA PHARMACEUTICALS INC
DFNDShares1.20M
TypeSH
Market value$7.93M
1.50%
Sole
0.00
Shared
1.20M
None
0.00
BRIGHT MINDS BIOSCIENCES INC
DFNDShares109.60K
TypeSH
Market value$7.69M
1.45%
Sole
0.00
Shared
109.60K
None
0.00
INFLARX NV
DFNDShares3.05M
TypeSH
Market value$6.82M
1.29%
Sole
0.00
Shared
3.05M
None
0.00
RELMADA THERAPEUTICS INC
DFNDShares842.11K
TypeSH
Market value$5.83M
1.10%
Sole
0.00
Shared
842.11K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ABIVAX SADFND | SPONSORED ADS | 604.31K | SH | $80.53M 15.22% | 0.00 | 604.31K | 0.00 |
VOR BIOPHARMA INCDFND | COM NEW | 1.70M | SH | $31.30M 5.91% | 0.00 | 1.70M | 0.00 |
IMMUNITYBIO INCDFND | COM | 3M | SH | $26.27M 4.97% | 0.00 | 3M | 0.00 |
VERA THERAPEUTICS INCDFND | CL A | 600.84K | SH | $25.78M 4.87% | 0.00 | 600.84K | 0.00 |
ZURA BIO LTDDFND | CLASS A ORD SHS | 4.22M | SH | $24.87M 4.70% | 0.00 | 4.22M | 0.00 |
ALUMIS INCDFND | COM | 856.06K | SH | $24.09M 4.55% | 0.00 | 856.06K | 0.00 |
SOL-GEL TECHNOLOGIES LTDDFND | SHS NEW | 274.36K | SH | $20.34M 3.84% | 0.00 | 274.36K | 0.00 |
ULTRAGENYX PHARMACEUTICAL INDFND | COM | 600K | SH | $20.03M 3.79% | 0.00 | 600K | 0.00 |
DEFINIUM THERAPEUTICS INCDFND | COM SHS | 425K | SH | $19.99M 3.78% | 0.00 | 425K | 0.00 |
ANNEXON INCDFND | COM | 3.50M | SH | $19.98M 3.78% | 0.00 | 3.50M | 0.00 |
ORUKA THERAPEUTICS INCDFND | COM | 183.33K | SH | $17.45M 3.30% | 0.00 | 183.33K | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSDFND | CLASS A ORD | 855.81K | SH | $16.66M 3.15% | 0.00 | 855.81K | 0.00 |
SAGIMET BIOSCIENCES INCDFND | COM SER A | 2.03M | SH | $15.69M 2.97% | 0.00 | 2.03M | 0.00 |
CONTINEUM THERAPEUTICS INCDFND | CL A | 921.48K | SH | $15.10M 2.85% | 0.00 | 921.48K | 0.00 |
IMMIX BIOPHARMA INCDFND | COM | 1.28M | SH | $13.17M 2.49% | 0.00 | 1.28M | 0.00 |
CLIMB BIO INCDFND | COM | 1M | SH | $13.04M 2.46% | 0.00 | 1M | 0.00 |
AMYLYX PHARMACEUTICALS INCDFND | COM | 700K | SH | $12.57M 2.38% | 0.00 | 700K | 0.00 |
NEKTAR THERAPEUTICSDFND | COM NEW | 175K | SH | $12.22M 2.31% | 0.00 | 175K | 0.00 |
NEUROGENE INCDFND | COM | 352.18K | SH | $11.08M 2.09% | 0.00 | 352.18K | 0.00 |
LB PHARMACEUTICALS INCDFND | COM SHS | 317.22K | SH | $10.30M 1.95% | 0.00 | 317.22K | 0.00 |
OPUS GENETICS INCDFND | COM | 1.97M | SH | $8.10M 1.53% | 0.00 | 1.97M | 0.00 |
EUPRAXIA PHARMACEUTICALS INCDFND | COM | 1.20M | SH | $7.93M 1.50% | 0.00 | 1.20M | 0.00 |
BRIGHT MINDS BIOSCIENCES INCDFND | COM NEW | 109.60K | SH | $7.69M 1.45% | 0.00 | 109.60K | 0.00 |
INFLARX NVDFND | COM | 3.05M | SH | $6.82M 1.29% | 0.00 | 3.05M | 0.00 |
RELMADA THERAPEUTICS INCDFND | COM | 842.11K | SH | $5.83M 1.10% | 0.00 | 842.11K | 0.00 |
Page 1 of 2